Clinical Trial Update: A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis [Phase 3]

View source ↗

Summary

This Phase 3 trial comparing mycophenolate mofetil to tacrolimus for membranous lupus nephritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glomerulonephritis
• Lupus Nephritis
• Membranous Nephropathy

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• Prograf (Tacrolimus)

Snippet

Sponsor: Hospital Authority, Hong Kong | Conditions: Lupus Nephritis, Glomerulonephritis, Membranous | Phase 3 | Status: COMPLETED